Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
Saama Technologies raises USD 40 Million to bolster AISaama Technologies has got a hefty investment of USD 40million to accelerate its Artificial Intelligence and bolster its use in the branch...
The oral depression drug of Sage Therapeutics meets phase 3 efficacyA phase 3 trial of oral treatment of Sage Therapeutics for postpartum depression (PPD) has hit its primary endpoin...
Human Immunodeficiency Virus or HIV is a species of Lentivirus (genus of retrovirus) th...
Progress is driven by innovation. When it comes to developing novel medications and the...
The HIV-1 treatment market for naïve and experienced patients is evolving consistently....
The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...
Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
